319 related articles for article (PubMed ID: 33920230)
1. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.
Troncone E; Marafini I; Stolfi C; Monteleone G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920230
[TBL] [Abstract][Full Text] [Related]
2. TGF-Beta signaling manipulation as potential therapy for IBD.
Marafini I; Zorzi F; Codazza S; Pallone F; Monteleone G
Curr Drug Targets; 2013 Nov; 14(12):1400-4. PubMed ID: 23489130
[TBL] [Abstract][Full Text] [Related]
3. Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer.
Stolfi C; Troncone E; Marafini I; Monteleone G
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375423
[TBL] [Abstract][Full Text] [Related]
4. Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases.
Zorzi F; Angelucci E; Sedda S; Pallone F; Monteleone G
Dig Liver Dis; 2013 Jul; 45(7):552-5. PubMed ID: 23287011
[TBL] [Abstract][Full Text] [Related]
5. Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.
Laudisi F; Dinallo V; Di Fusco D; Monteleone G
Curr Drug Metab; 2016; 17(3):303-6. PubMed ID: 26651974
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
[TBL] [Abstract][Full Text] [Related]
7. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 and Smad7 in the regulation of IBD.
Monteleone G; Boirivant M; Pallone F; MacDonald TT
Mucosal Immunol; 2008 Nov; 1 Suppl 1():S50-3. PubMed ID: 19079231
[TBL] [Abstract][Full Text] [Related]
9. Role of Smad7 in inflammatory bowel diseases.
Monteleone G; Caruso R; Pallone F
World J Gastroenterol; 2012 Oct; 18(40):5664-8. PubMed ID: 23155305
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.
Izzo R; Bevivino G; De Simone V; Sedda S; Monteleone I; Marafini I; Di Giovangiulio M; Rizzo A; Franzè E; Colantoni A; Ortenzi A; Monteleone G
Inflamm Bowel Dis; 2018 May; 24(6):1213-1224. PubMed ID: 29668937
[TBL] [Abstract][Full Text] [Related]
11. Smad7 as a positive regulator of intestinal inflammatory diseases.
Monteleone G; Laudisi F; Stolfi C
Curr Res Immunol; 2023; 4():100055. PubMed ID: 36714553
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.
Troncone E; Marafini I; Stolfi C; Monteleone G
Front Immunol; 2018; 9():1407. PubMed ID: 29973939
[TBL] [Abstract][Full Text] [Related]
13. The TGF-β/Smad System in IBD Pathogenesis.
Sedda S; Marafini I; Dinallo V; Di Fusco D; Monteleone G
Inflamm Bowel Dis; 2015 Dec; 21(12):2921-5. PubMed ID: 26230862
[TBL] [Abstract][Full Text] [Related]
14. Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.
Monteleone I; Marafini I; Zorzi F; Di Fusco D; Dinallo V; Rizzo A; Sileri P; Sica G; Monteleone G
J Crohns Colitis; 2016 Jun; 10(6):670-7. PubMed ID: 26818761
[TBL] [Abstract][Full Text] [Related]
15. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal Regulation Between Smad7 and Sirt1 in the Gut.
Sedda S; Franzè E; Bevivino G; Di Giovangiulio M; Rizzo A; Colantoni A; Ortenzi A; Grasso E; Giannelli M; Sica GS; Fantini MC; Monteleone G
Front Immunol; 2018; 9():1854. PubMed ID: 30147698
[TBL] [Abstract][Full Text] [Related]
17. High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.
Sedda S; De Simone V; Marafini I; Bevivino G; Izzo R; Paoluzi OA; Colantoni A; Ortenzi A; Giuffrida P; Corazza GR; Vanoli A; Di Sabatino A; Pallone F; Monteleone G
Immunology; 2017 Mar; 150(3):356-363. PubMed ID: 27861825
[TBL] [Abstract][Full Text] [Related]
18. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
19. Gadd45β promotes regeneration after injury through TGFβ-dependent restitution in experimental colitis.
Hwang JH; Kim TH; Kim YH; Noh JR; Choi DH; Kim KS; Lee EY; Kim BC; Kim MH; Kim H; Lee TG; Lee JS; Lee CH
Exp Mol Med; 2019 Oct; 51(10):1-14. PubMed ID: 31666502
[TBL] [Abstract][Full Text] [Related]
20. CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.
Marafini I; Monteleone I; Dinallo V; Di Fusco D; De Simone V; Laudisi F; Fantini MC; Di Sabatino A; Pallone F; Monteleone G
J Crohns Colitis; 2017 May; 11(5):603-609. PubMed ID: 28453765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
